http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104411686-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-86 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate | 2013-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104411686-B |
| titleOfInvention | The manufacture method of 4-[5-(pyridin-4-yl)-1H-1,2,4-triazole-3-base] pyridine-2-nitrile and intermediate |
| abstract | The present invention provides industrial favourable manufacture method and the intermediate of 4 [5 (pyridine 4 base) 1H 1,2,4 triazole 3 base] pyridine 2 nitrile useful as medicine.The intermediate that the manufacture method of the compound of formula based on following reaction equation (1) and following formula (4) represent. |
| priorityDate | 2012-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.